en · de · es · fr · pt
sr9009-notes.peptides4800.com › Faq › Mechanism And Preclinical Findings — What the Evidence Shows

Mechanism And Preclinical Findings — What the Evidence Shows

By Editorial Desk · published 2025-09-15 · last reviewed 2025-10-01 · Faq

The short version of NR1D1 fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2025-10-01. Anything still debated is marked as such rather than presented as settled.

Mechanism and Preclinical Findings

SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

Detection, Regulation, and Misconceptions

Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.

Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.

Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall molecule; not a steroid or peptide.
Primary targetsNR1D1 and NR1D2Also known as REV-ERBα and REV-ERBβ.
Studied routesIntraperitoneal in rodentsOral bioavailability in humans is not established.
Human approvalNo approved therapeutic indicationNo recognized clinical use.
Key uncertaintyHuman physiological effectsPreclinical findings may not translate.

Background and Research Status

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

Related pages on this site

Further detail

== Awards and honors == In-N-Out Burger was ranked number 28 among America's Best Employers 2019 by Forbes. According to a survey by Glassdoor in 2014, In-N-Out Burger ranked No. 8 on its annual list of the 50 best places to work in the U.S. and the U.K. The company reached No. 6 in Glassdoor's 2024 Top 100 Ranking.

== SE == se – (s) Northern Sami language (ISO 639-1 code) Se – (s) Selenium SE (s) Seychelles (FIPS 10-4 country code) (i) Societas Europaea (form of business organization in the EU) South-east (s) Sweden (ISO 3166 digram) (i) Synthetic Environment Systems engineering SEAD – (i) Suppression of Enemy Air Defence(s) SEADI – (i) Senior Executioner of Approved Driving Instructors SEAFDEC – (p) Southeast Asian Fisheries Development Center SEAL – (p) SEa-Air-Land SEAT – (a) Sociedad Española de Automóviles de Turismo (Spanish for "Spanish Touring Car Company") SEATO – (a) Southeast Asia Treaty Organization SeaWiFS – (p) Sea-Viewing Wide Field of View Sensor (satellite instrument) SEC (i) U.S. Securities and Exchange Commission (p) Security Southeastern Conference SECaaS - (p) Security-as-a-Service SECAM – (a) Séquentiel couleur à mémoire (French for "Colour Sequential with Memory"; TV standard, cf. NTSC, PAL) SECDEF – (p) (U.S.) Secretary of Defense SED – (i) CERDEC Software Engineering Directorate SEDRIS – (a) Synthetic Environment Data Representation and Interchange Specification SEE – (a) Small Emplacement Excavator SEG – (i) Society of Exploration Geophysicists SEG – (i) Special Escort Group SEK – (s) Swedish krona (ISO 4217 currency code) Selkent – (p) South East London & Kent Bus Company SELT – (a) Single Ended Line Test (ing) SEM (i/a) Sensor Employment Manager Switch to Email Mode, i.e.

=== NNPC, NEITI Set Up Joint Committee to Strengthen Transparency === In keeping with the Transparency, Accountability, and Performance Excellence (TAPE) agenda of the Mele Kyari-led management of the Nigerian National Petroleum Corporation (NNPC), the corporation and the Nigeria Extractive Industries Transparency Initiative (NEITI) have set up a joint committee to deepen collaboration in order to promote transparency in the Oil and Gas Industry. Speaking at the inauguration of the NNPC-NEITI Joint Committee on Mainstreaming and Remedial Issues, group managing director of NNPC, Kyari, said the joint committee was part of efforts to further deepen the robust history of collaboration that both organisations had enjoyed over the years. He said NNPC was in complete sync with the activities of NEITI because it was the right of the over 200 million Nigerians who are the shareholders of the corporation to know everything about the operations of their company.

Sources: en.wikipedia.org

Supporting material

(123Te is expected to decay to 123Sb, but the half-life appears to be so long that the decay has never been observed.) There are no stable nuclides having atomic number greater than Z = 82 (lead), although bismuth (Z = 83) is stable for all practical human purposes, and thorium (Z = 90) and uranium (Z = 92) are sufficiently long-lived to occur on Earth in large quantities. Elements with atomic numbers from 1 to 82 all have stable isotopes, with the exceptions of technetium (Z = 43) and promethium (Z = 61).

== Stem cells == Cells in Wharton's jelly express several stem cell genes, including telomerase. They can be extracted, cultured, and induced to differentiate into mature cell types such as chondrocytes and adipocytes. Wharton's jelly is therefore a potential source of adult stem cells, often collected from cord blood.

=== United Kingdom === The National Health Service (NHS) makes several treatments available for people with sickle cell disease. These include pain management, antibiotics, and vaccinations to reduce the risk of infection, and blood transfusions where appropriate. Other treatments include Voxelotor which reduces the need for blood transfusions, and the gene therapy Casgevy. In England, a number of regional centres coordinate treatment for sickle cell disease and other haemoglobinopathies.

== Businesspeople == Henry Rutgers (1766), Revolutionary War hero, businessman, philanthropist, and namesake of Rutgers University Leffert Lefferts (1794), first president of Long Island Bank William Bard (1798), son of physician Samuel Bard, founder and first president of New York Life Insurance Company Stephen Price (1799), theatrical manager who managed Park Theatre in Manhattan and Theatre Royal, Drury Lane in London William Backhouse Astor Sr.* (1811), son of John Jacob Astor Cornelius Roosevelt* (attended, year unknown), member of the Roosevelt family, one of the founders of the Chemical Bank; great-grandfather of Theodore Roosevelt James H. Roosevelt (1819), founder of Roosevelt Hospital Robert Goelet Sr. (1828), banker and real estate developer who was associated with the founding of the Chemical Bank Bradish Johnson (1831), industrialist involved in the Swill milk scandal Robert L. Cutting (1830), co-founder of the Continental Bank of New York and president of the New York Stock Exchange Henry T. Anthony (1832), photographer, vice-president of the E. & H. T. Anthony & Company Adrian G Iselin* (1837), financier, banker Edward Anthony (1838), photographer and founder of E. & H. T. Anthony & Company, largest manufacturer and distributor of photographic supplies in the U.S. during the 19th century John Jacob Astor III (1839), son of William Backhouse Astor Sr.

Sources: en.wikipedia.org

Notes from published material

=== Discontinued === Alprazolam inhalation (AZ-002; FNP-002; Staccato® alprazolam; STAP-001; UCB-7538) – GABAA receptor positive allosteric modulator and benzodiazepine [7] Alprazolam intranasal (Panistat) – GABAA receptor positive allosteric modulator and benzodiazepine [8] BTG-1640 (ABIO-08/01; ABIO-0801) – undefined mechanism of action [9] Eglumetad (Eglumegad; LY-354740) – metabotropic glutamate mGlu2 and mGlu3 receptor agonist [10] JNJ-19567470 (CRA-5626; R-317573) – corticotropin releasing factor receptor 1 (CRF1R) antagonist [11] Nefazodone (BMY-13754; Dutonin; MJ-13754; MS-13754; Nefadar; Serzone) – serotonin 5-HT1A receptor ligand, serotonin 5-HT2A and 5-HT2C receptor antagonist, α1- and α2-adrenergic receptor antagonist, weak serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), and other actions [12] Xenon (NBTX-001) – ionotropic glutamate NMDA receptor antagonist [13]

Curing is any of various food preservation and flavoring processes of foods such as meat, fish and vegetables, by the addition of salt, with the aim of drawing moisture out of the food by the process of osmosis. Because curing increases the solute concentration in the food and hence decreases its water potential, the food becomes inhospitable for the microbial growth that causes food spoilage. Smoking and salting techniques improve on the drying process and add antimicrobial agents that aid in preservation. Smoke deposits a number of pyrolysis products onto the food, including the phenols syringol, guaiacol and catechol. Salt accelerates the drying process using osmosis and also inhibits the growth of several common strains of bacteria. More recently nitrites have been used to cure meat, contributing a characteristic pink colour. In 2015, the International Agency for Research on Cancer of the World Health Organization classified processed meat—i.e., meat that has undergone salting, curing, and smoking—as "carcinogenic to humans".

In mammals, methylation occurs in the liver by methyltransferases, the products being the dimethylarsinous acid ((CH3)2AsOH) and dimethylarsinic acid ((CH3)2As(O)OH), which have the oxidation states As(III) and As(V), respectively. Although the mechanism of methylation of arsenic in humans has not been elucidated, the source of methyl is methionine, which suggests a role of S-adenosyl methionine. Exposure to toxic doses begin when the liver's methylation capacity is exceeded or inhibited. There are two major forms of arsenic that can enter the body, arsenic (III) and arsenic (V). Arsenic (III) enters the cells though aquaporins 7 and 9, which is a type of aquaglyceroporin. Arsenic (V) compounds use phosphate transporters to enter cells. The arsenic (V) can be converted to arsenic (III) by the enzyme purine nucleoside phosphorylase. This is classified as a bioactivation step, as although arsenic (III) is more toxic, it is more readily methylated. There are two routes by which inorganic arsenic compounds are methylated. The first route uses Cyt19 arsenic methyltransferase to methylate arsenic (III) to a mono-methylated arsenic (V) compound. This compound is then converted to a mono-methylated arsenic (III) compound using Glutathione S-Transferase Omega-1 (GSTO1). The mono-methylated arsenic (V) compound can then be methylated again by Cyt19 arsenic methyltransferase, which forms a dimethyl arsenic (V) compound, which can be converted to a dimethyl arsenic (III) compound by Glutathione S-Transferase Omega-1 (GTSO1).

Karin Markides, born 1951, is a Swedish professor in analytical chemistry and president and CEO of Okinawa Institute of Science and Technology from 1 June 2023. She was the president of American University of Armenia from 1 July 2019 to 2 December 2022. She was also the president and CEO of Chalmers University of Technology from 2006 to 2015. From 2004 to 2006 she was vice director general for Vinnova. She is also board member of the Royal Swedish Academy of Engineering Sciences since 1992 and a board member of the Royal Swedish Academy of Sciences since 1999. Markides completed her doctorate degree at Stockholm University 1984 with the thesis Organosiloxanes containing cyano groups for capillary chromatography. Following this she started her research career at Brigham Young University in Utah, USA, first as a postdoc, and later as research assistant and associate director. In May 1990 she returned to Sweden as a professor at Uppsala University. Fourteen years later, in May 2004, she was employed as vice director general of Vinnova, the Swedish innovation agency. Markides has been chairman of the Scientific Council for Sustainable Development under the Swedish government (vetenskapliga rådet för hållbar utveckling) since 2015. The council's mission is to give evidence-based, concrete suggestions for development of financial, ecological, cultural and social sustainability for the government's longterm sustainability vision.

By August 2023, representatives were saying that what would take place in 2024 would be a smaller "exhibition", with a "full event" taking place in 2025. In 2023, CNN questioned the viability of the event; however, in May 2025, the organization announced plans to hold the games in May 2026 at Resorts World Las Vegas, and that the sports included are to be swimming, track and field, and weightlifting. The event took place on May 24, 2026. Kristian Gkolomeev beat the current non-drug-assisted world record for 50-meter freestyle. TEG reported that 12 athletes had beaten their personal records. Mainstream media generally described the inaugural Enhanced Games as a flop, with the performances and results described by commentators as underwhelming. After the event, stock for A Paradise Acquisition Corp., the Enhanced Games' parent company, dropped by 70%.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

How does SR9009 differ from typical receptor agonists?

REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.

Has SR9009 been tested in humans?

Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.

Is SR9009 legal to buy?

Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.

Network